Drug recall · May 28, 2014
Esbelin Siloutte Te recall
Why: Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Esbelin Siloutte Te, Suplemento Alimenticio, herbal tea in a gold foil/plastic zip-lock pouch. Hecho en Mexico Por: Herbal Give Care, Av Independencia # 1016, Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7562684652553
- Lots / codes
All lots
- Quantity
- 311 pouches
- Company
- Herbal Give Care Llc, Grand Prairie, TX
- Distribution
- Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.
- Initiated
- July 19, 2013 · Voluntary: Firm initiated
- Classified
- May 20, 2014
- Reported
- May 28, 2014
- Ended
- August 21, 2015
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.